Elevation Wealth Partners’s Labcorp LH Stock Holding History

Elevation Wealth Partners’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$207K	Buy	672 +4	+0.6%	+$1.24K	0.06%	141
2026 Q2	$187K	Sell	668 -13	-2%	-$3.42K	0.06%	144
2026 Q1	$182K	Sell	681 -2	-0.3%	-$542	0.07%	123
2025 Q4	$171K	Sell	683 -80	-10%	-$21.2K	0.06%	126
2025 Q3	$219K	Buy	763 +3	+0.4%	+$804	0.08%	110
2025 Q2	$200K	Hold	760	–	–	0.08%	113
2025 Q1	$177K	Hold	760	–	–	0.08%	122
2024 Q4	$174K	Hold	760	–	–	0.07%	124
2024 Q3	$170K	Hold	760	–	–	0.07%	126
2024 Q2	$155K	Hold	760	–	–	0.07%	129
2024 Q1	$166K	Hold	760	–	–	0.08%	123
2023 Q4	$153K	Buy	+760	New	+$160K	0.09%	117

Other funds holding LH

Cooke & Bieler Philadelphia, Pennsylvania $6.36B AUM 0.55% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

AMI Asset Management Los Angeles, California $1.74B AUM 24.77% 1-Year Est. Return

Davidson Investment Advisors Great Falls, Montana $2.39B AUM 16.28% 1-Year Est. Return

Everett Harris & Co Los Angeles, California $8.46B AUM 13.48% 1-Year Est. Return

Deroy & Devereaux Private Investment Counsel Bloomfield Hills, Michigan $2.31B AUM 43.14% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Willis Investment Counsel Gainesville, Georgia $1.97B AUM 25.29% 1-Year Est. Return

McRae Capital Management Morristown, New Jersey $540M AUM 15.41% 1-Year Est. Return

Elevation Wealth Partners's LH Position: Q3 2026 in Review

Elevation Wealth Partners increased its Labcorp (LH) stake by 0.6% in Q3 2026, buying an estimated $1.24K and bringing the position to 672 shares worth $207K. The position accounts for 0.06% of the portfolio, ranked #141.

Elevation Wealth Partners first reported a position in LH in Q4 2023 and has held it in 12 quarters since. The position peaked at $219K in Q3 2025. 335 funds tracked by Wall St. Rank hold LH as of Q3 2026.

Elevation Wealth Partners held 672 shares of Labcorp worth $207K as of Q3 2026.
Elevation Wealth Partners bought 4 Labcorp shares in Q3 2026, an estimated $1.24K.
Labcorp made up 0.06% of Elevation Wealth Partners's portfolio in Q3 2026, its #141 holding.
Elevation Wealth Partners first reported a position in Labcorp in Q4 2023 and has held it in 12 quarters since.
Elevation Wealth Partners's Labcorp position peaked at $219K in Q3 2025.
335 funds tracked by Wall St. Rank held Labcorp as of Q3 2026.

Based on Elevation Wealth Partners's 13F filing for Q3 2026, filed 7 Oct 2026.